Flunixin meglumine
Flunixin Meglumine is a potent, non-narcotic NSAID with analgesic and antipyretic properties. Researchers utilize this API to study the inhibition of prostaglandin synthesis in equine, bovine, and porcine models.
Description
Comprehensive Product Overview
In the field of veterinary pharmacology, the reversible inhibition of pro-inflammatory enzymes defines the standard of care for acute pain. Specifically, Flunixin Meglumine functions by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing the production of prostaglandins that mediate pain, fever, and inflammation. Additionally, researchers select this molecule to study its unique ability to mitigate the effects of circulating endotoxins, which is critical in managing septic shock in large animals. Therefore, whether you investigate musculoskeletal disorders or acute mastitis, this API delivers reliable pharmacological support across various laboratory conditions.
Zyntex maintains a transparent production chain to ensure a precise impurity profile for every batch, focusing on the absence of residual solvents and heavy metals. Moreover, our quality control team verifies every lot for particle size consistency and solubility to ensure the stability of injectable and oral paste formulations. For instance, we optimize the crystalline structure to support the development of high-bioavailability transdermal delivery systems used in livestock research. As a result, your lab receives a high-purity reagent for advanced studies into arachidonic acid metabolism and the modulation of inflammatory cytokines.
Modern veterinary science relies on high-quality NSAIDs to understand the complex pathways of pain transmission in non-human subjects. Because Flunixin Meglumine possesses a documented rapid onset of action and superior potency compared to phenylbutazone in certain models, it remains a primary focus for studies involving post-operative recovery and chronic arthritis management. Ultimately, Zyntex provides a dependable foundation for your next innovation in animal welfare and specialized pharmaceutical engineering.
Specialized Veterinary Applications
This high-potency anti-inflammatory agent is vital for the following research and production sectors:
🐎 Equine Pain Management
Scientists use Flunixin Meglumine to investigate the alleviation of visceral pain associated with colic and musculoskeletal inflammation.
🐄 Bovine Respiratory Health
Researchers include this API in protocols focused on reducing pyrexia and lung consolidation in cattle during acute infectious outbreaks.
🧪 Endotoxemia Research
Biotechnicians utilize this molecule to study the protective effects against hemodynamic changes induced by bacterial lipopolysaccharides (LPS).
💊 Pharmaceutical Formulation
This compound serves as a core reactant for engineering stable, 50mg/mL injectable solutions and specialized pour-on formulations.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Flunixin Meglumine (CAS 42461-84-7) |
| Molecular Formula | C14H11F3N2O2 · C7H17NO5 |
| Purity | USP / BP / EP Grade (Min. 99%) |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in Water and Ethanol |
🔬 Scientific Data: For detailed pharmacokinetics, toxicity profiles, and metabolic studies, consult: PubChem Entry: Flunixin Meglumine (External Link)
